Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2021Annals of the Rheumatic DiseasesOpen Access

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJames Cheng‐Chung WeiChina Medical UniversityTKTae‐Hwan KimHallym UniversityMKMitsumasa KishimotoKyorin University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wei et al. (2021) studied this question.

synapsesocial.com/papers/6a9147969cd0eb66ad33f785https://doi.org/10.1136/annrheumdis-2020-219406
View Full Paper
Ask AI
Bookmark
Share